Michael Raab - 06 Jun 2024 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Director
Signature
/s/ Christian Formica, Attorney-in-Fact
Issuer symbol
FOLD
Transactions as of
06 Jun 2024
Transactions value $
$0
Form type
4
Filing time
07 Jun 2024, 19:44:34
Previous filing
31 May 2024
Next filing
14 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Award $0 +11.8K +14.17% $0.00 95.4K 06 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Award $0 +42.5K $0.00 42.5K 06 Jun 2024 Common Stock 42.5K $10.27 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
F2 One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant.